317 related articles for article (PubMed ID: 27445459)
1. Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials.
Toussirot E; Vauchy C; Binda D; Michel F
Drug Des Devel Ther; 2016; 10():2087-94. PubMed ID: 27445459
[TBL] [Abstract][Full Text] [Related]
2. An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis.
Paccou J; Flipo RM
Drug Des Devel Ther; 2016; 10():2255-62. PubMed ID: 27468228
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
[TBL] [Abstract][Full Text] [Related]
4. Golimumab for treatment of axial spondyloarthritis.
Rios Rodriguez V; Poddubnyy D
Immunotherapy; 2016 Feb; 8(2):107-15. PubMed ID: 26798943
[TBL] [Abstract][Full Text] [Related]
5. New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agents.
Toussirot E
Expert Opin Pharmacother; 2017 Feb; 18(3):275-282. PubMed ID: 28099816
[TBL] [Abstract][Full Text] [Related]
6. New evidence on the management of spondyloarthritis.
Sieper J; Poddubnyy D
Nat Rev Rheumatol; 2016 May; 12(5):282-95. PubMed ID: 27052489
[TBL] [Abstract][Full Text] [Related]
7. Golimumab for the treatment of axial spondyloarthritis.
Gelfer G; Perry L; Deodhar A
Expert Rev Clin Immunol; 2016; 12(1):9-18. PubMed ID: 26523483
[TBL] [Abstract][Full Text] [Related]
8. Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.
Poddubnyy D; Haibel H; Braun J; Rudwaleit M; Sieper J
Arthritis Rheumatol; 2015 Sep; 67(9):2369-75. PubMed ID: 26017497
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis.
Sieper J; van der Heijde D; Dougados M; Maksymowych WP; Scott BB; Boice JA; Berd Y; Bergman G; Curtis S; Tzontcheva A; Huyck S; Weng HH
Arthritis Rheumatol; 2015 Oct; 67(10):2702-12. PubMed ID: 26139307
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological management of axial spondyloarthritis in adults.
Toussirot E
Expert Opin Pharmacother; 2019 Aug; 20(12):1483-1491. PubMed ID: 31095430
[No Abstract] [Full Text] [Related]
11. The role of secukinumab in the treatment of ankylosing spondylitis.
Shah R; Perry L; Deodhar A
Immunotherapy; 2015; 7(12):1241-7. PubMed ID: 26595091
[TBL] [Abstract][Full Text] [Related]
12. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
Ward MM; Deodhar A; Akl EA; Lui A; Ermann J; Gensler LS; Smith JA; Borenstein D; Hiratzka J; Weiss PF; Inman RD; Majithia V; Haroon N; Maksymowych WP; Joyce J; Clark BM; Colbert RA; Figgie MP; Hallegua DS; Prete PE; Rosenbaum JT; Stebulis JA; van den Bosch F; Yu DT; Miller AS; Reveille JD; Caplan L
Arthritis Rheumatol; 2016 Feb; 68(2):282-98. PubMed ID: 26401991
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
Callhoff J; Sieper J; Weiß A; Zink A; Listing J
Ann Rheum Dis; 2015 Jun; 74(6):1241-8. PubMed ID: 24718959
[TBL] [Abstract][Full Text] [Related]
14. Biologics in spondyloarthritis: TNFα inhibitors and other agents.
Toussirot É
Immunotherapy; 2015; 7(6):669-81. PubMed ID: 26058432
[TBL] [Abstract][Full Text] [Related]
15. Biologic therapies for spondyloarthritis: what is new?
Baraliakos X; Braun J
Curr Rheumatol Rep; 2012 Oct; 14(5):422-7. PubMed ID: 22855297
[TBL] [Abstract][Full Text] [Related]
16. Axial spondyloarthritis: thoughts about nomenclature and treatment targets.
Braun J
Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S132-5. PubMed ID: 23079005
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.
Monti S; Todoerti M; Codullo V; Favalli EG; Biggioggero M; Becciolini A; Montecucco C; Caporali R
Mod Rheumatol; 2018 May; 28(3):542-549. PubMed ID: 28880727
[TBL] [Abstract][Full Text] [Related]
18. Golimumab for the treatment of axial spondyloarthritis.
Palazzi C; D'angelo S; Gilio M; Leccese P; Padula A; Olivieri I
Expert Opin Biol Ther; 2017 Jan; 17(1):129-133. PubMed ID: 27817204
[TBL] [Abstract][Full Text] [Related]
19. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
Ward MM; Deodhar A; Gensler LS; Dubreuil M; Yu D; Khan MA; Haroon N; Borenstein D; Wang R; Biehl A; Fang MA; Louie G; Majithia V; Ng B; Bigham R; Pianin M; Shah AA; Sullivan N; Turgunbaev M; Oristaglio J; Turner A; Maksymowych WP; Caplan L
Arthritis Rheumatol; 2019 Oct; 71(10):1599-1613. PubMed ID: 31436036
[TBL] [Abstract][Full Text] [Related]
20. [Spondyloarthritides].
Rudwaleit M
Internist (Berl); 2017 Jul; 58(7):687-701. PubMed ID: 28593426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
